Clinical impact of perineural cancer invasion detected in prostate cores: Involvement of spatially contiguous versus separate biopsy sites
Pathology International · 2023
DOI: 10.1111/pin.13356 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pathology International, 2023. Verfasst von Yuki Teramoto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Urology, University of Rochester Medical Center, Rochester, New York, USA.
ORCID-Profile: Yuki Teramoto, Hiroshi Miyamoto
Zitieren
APA
Teramoto, Y., Numbere, N., & Miyamoto, H. (2023). Clinical impact of perineural cancer invasion detected in prostate cores: Involvement of spatially contiguous versus separate biopsy sites. Pathology International. https://doi.org/10.1111/pin.13356
Vancouver
Teramoto Y, Numbere N, Miyamoto H. Clinical impact of perineural cancer invasion detected in prostate cores: Involvement of spatially contiguous versus separate biopsy sites. Pathology International. 2023. doi:10.1111/pin.13356
BibTeX
@article{Teramoto2023,
author = {Teramoto, Yuki and Numbere, Numbereye and Miyamoto, Hiroshi},
title = {Clinical impact of perineural cancer invasion detected in prostate cores: Involvement of spatially contiguous versus separate biopsy sites},
journal = {Pathology International},
year = {2023},
doi = {10.1111/pin.13356}
}
EUVIMED